Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 12:40 pm Purchase | 2021-12-31 | 13G | INmune Bio, Inc. INMB | Xencor Inc XNCR | 1,885,533 10.600% | 194,533 (+11.50%) | Filing History |
| 2022-02-10 12:29 pm Sale | 2021-12-31 | 13G | Xencor, Inc. XNCR | PRIMECAP MANAGEMENT CO/CA/ | 4,987,822 8.530% | -352,600 (-6.60%) | Filing History |
| 2022-02-10 08:47 am Purchase | 2021-12-31 | 13G | Xencor, Inc. XNCR | The Vanguard Group | 6,324,776 10.810% | 324,495 (+5.41%) | Filing History |
| 2022-02-09 10:04 am Sale | 2022-02-08 | 13G | Xencor, Inc. XNCR | FMR LLC | 7,761,578 13.271% | -856,846 (-9.94%) | Filing History |
| 2022-01-28 1:54 pm Purchase | 2021-12-31 | 13G | Xencor, Inc. XNCR | BlackRock Inc. BLK | 9,334,830 16.000% | 105,342 (+1.14%) | Filing History |
| 2021-07-12 2:57 pm Purchase | 2021-06-30 | 13G | Xencor, Inc. XNCR | T. Rowe Price Associates, Inc. | 5,863,909 10.000% | 173,553 (+3.05%) | Filing History |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | Xencor, Inc. XNCR | T. Rowe Price Associates, Inc. | 5,690,356 9.900% | -19,024 (-0.33%) | Filing History |
| 2021-02-12 12:02 pm Sale | 2009-02-28 | 13G | Xencor, Inc. XNCR | PRIMECAP MANAGEMENT CO/CA/ | 5,340,422 9.290% | -112,650 (-2.07%) | Filing History |
| 2021-02-10 12:04 pm Purchase | 2020-12-31 | 13G | Xencor, Inc. XNCR | The Vanguard Group | 6,000,281 10.440% | 233,012 (+4.04%) | Filing History |
| 2021-02-08 10:35 am Purchase | 2021-02-05 | 13G | Xencor, Inc. XNCR | FMR LLC | 8,618,424 15.000% | 110,249 (+1.30%) | Filing History |
| 2021-01-25 4:49 pm Purchase | 2020-12-31 | 13G | Xencor, Inc. XNCR | BlackRock Inc. BLK | 9,229,488 16.100% | 1,004,007 (+12.21%) | Filing History |
| 2021-01-22 5:01 pm Purchase | 2020-12-31 | 13G | INmune Bio, Inc. INMB | Xencor Inc XNCR | 1,691,000 12.500% | 36,000 (+2.18%) | Filing History |
| 2021-01-11 12:07 pm Purchase | 2020-12-16 | 13G | MIRAGEN THERAPEUTICS INC MGEN | Xencor Inc XNCR | 322,407 7.600% | 322,407 (New Position) | Filing History |